Skip to main content

Table 1 Main characteristics of the studies included in this meta-analysis

From: Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis

References

Study location

Study design

Method of RBP4 measurement

Diagnostic methods of NAFLD

Quality Score

Additional information

Seo et al. [14]

Korea

Cross-sectional

ELISA

Ultrasound

3

 

Chen et al. [15]

China

Cross-sectional

ELISA

Ultrasound

3

 

Milner et al. [16]

Australia

Cross-sectional

ELISA

Liver biopsy

7

 

Suh et al. [17]

Korea

Cross-sectional

ELISA

Ultrasound

4

 

Schina et al. [18]

Greece

Cross-sectional

ELISA

Liver biopsy

4

 

Polyzos et al. [19]

Greece

Cross-sectional

ELISA

Liver biopsy

5

A second control group of 24 lean subjects was not included in the meta-analysis.

Auguet et al. [23]

Spain

Cross-sectional

ELISA

Liver biopsy

6

Patients and controls were morbidly obese women who underwent bariatric surgery.

Koh et al. [24]

Korea

Cross-sectional

ELISA

Ultrasound

5

NAFLD cases and controls were all type 2 diabetic patients.

Wu et al. [25]

China

Cross-sectional

Radioimmunoa- ssay

Ultrasound

3

NAFLD cases and controls were all type 2 diabetic patients.

Cengiz et al. [26]

Turkey

Cross-sectional

ELISA

Ultrasound and liver biopsy

3

34 of 76 NAFLD underwent a liver biopsy.

Kashyap et al. [27]

USA

Cross-sectional

ELISA

Liver biopsy

6

Patients and controls were subjected to bariatric surgery

Alkhouri et al. [28]

USA

Cross-sectional

ELISA

Liver biopsy

4

 
  1. RBP4 retinol binding protein 4, NAFLD nonalcoholic fatty liver disease